Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode Licenses Patents to Molecular Devices

NEW YORK (GenomeWeb) – Applied BioCode said today that it has signed a license and supply agreement for its barcoded magnetic bead (BMB) technology with bioanalytics firm Molecular Devices.

The deal gives Molecular Devices access to specific Applied BioCode BMB patents for use on its own microplate reading devices within the life sciences, food and beverage research, and environmental testing markets. Further details of the agreement were not disclosed.

“Our barcoded magnetic bead technology combined with Molecular Devices microplate reading devices will expand its capabilities from single to multiple analyte tests and create a formidable force for multiplexed testing within these markets," Winston Ho, president of Applied BioCode, said in a statement.